AG
LJPC

Advisor Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Advisor Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5K Hold
1,375
– – ﹤0.01% 4716
2019
Q3 		$12K Sell
1,375
-500
-27% -$4.72K ﹤0.01% 4266
2019
Q2 		$17K Sell
1,875
-1,125
-38% -$8.48K ﹤0.01% 4093
2019
Q1 		$19K Buy
+3,000
New +$19.5K ﹤0.01% 4030
2018
Q3 		– Sell
-35
Closed -$1K – 5436
2018
Q2 		$1K Hold
35
– – ﹤0.01% 4903
2018
Q1 		$1K Hold
35
– – ﹤0.01% 4926
2017
Q4 		$1K Hold
35
– – ﹤0.01% 4931
2017
Q3 		$1K Buy
+35
New +$1.13K ﹤0.01% 4812

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Group's LJPC Position: Q4 2019 in Review

Advisor Group held its La Jolla Pharmaceutical Company (LJPC) position steady in Q4 2019 at 1,375 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4716.

Advisor Group first reported a position in LJPC in Q3 2017 and has held it in 8 quarters since. The position peaked at $19K in Q1 2019. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

  • Advisor Group held 1,375 shares of La Jolla Pharmaceutical Company worth $5K as of Q4 2019.
  • Advisor Group left its La Jolla Pharmaceutical Company share count unchanged in Q4 2019.
  • La Jolla Pharmaceutical Company made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4716 holding.
  • Advisor Group first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and has held it in 8 quarters since.
  • Advisor Group's La Jolla Pharmaceutical Company position peaked at $19K in Q1 2019.
  • 77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.